GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‘Cell Lymphoma CD5 CAR-NK Therapy
1 day ago
1
-
Homepage
-
Finance
- GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T‘Cell Lymphoma CD5 CAR-NK Therapy